Kyverna Therapeutics (KYTX) News Today → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free KYTX Stock Alerts $13.52 +0.39 (+2.97%) (As of 06/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 4:05 PM | prnewswire.comKyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews ImmunologyJune 10 at 2:56 PM | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Trading Up 5.7%Kyverna Therapeutics (NASDAQ:KYTX) Shares Up 5.7%June 8 at 8:16 AM | americanbankingnews.comKyverna Therapeutics (NASDAQ:KYTX) Stock Price Down 5.4%June 6, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Trading Down 5.4%Kyverna Therapeutics (NASDAQ:KYTX) Stock Price Down 5.4%June 4, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Stock Price Up 6.9%Kyverna Therapeutics (NASDAQ:KYTX) Stock Price Up 6.9%June 3, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Gap Up to $12.53Kyverna Therapeutics (NASDAQ:KYTX) Shares Gap Up to $12.53June 1, 2024 | americanbankingnews.comKyverna Therapeutics (NASDAQ:KYTX) Stock Price Down 3.7%May 31, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Sets New 1-Year Low at $11.75Kyverna Therapeutics (NASDAQ:KYTX) Reaches New 1-Year Low at $11.75May 30, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Down 3.7% Kyverna Therapeutics (NASDAQ:KYTX) Shares Down 3.7%May 29, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Sees Unusually-High Trading VolumeKyverna Therapeutics (NASDAQ:KYTX) Sees Unusually-High Trading VolumeMay 24, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Up 6.4%Kyverna Therapeutics (NASDAQ:KYTX) Trading 6.4% HigherMay 23, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Reaches New 1-Year Low at $12.16Kyverna Therapeutics (NASDAQ:KYTX) Sets New 1-Year Low at $12.16May 20, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Down 4.7% Kyverna Therapeutics (NASDAQ:KYTX) Shares Down 4.7%May 17, 2024 | marketbeat.comKyverna Therapeutics, Inc. Expected to Post Q2 2024 Earnings of ($0.69) Per Share (NASDAQ:KYTX)Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Research analysts at Leerink Partnrs reduced their Q2 2024 earnings per share (EPS) estimates for Kyverna Therapeutics in a report released on Tuesday, May 14th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnMay 16, 2024 | markets.businessinsider.comBuy Rating for Kyverna Therapeutics Based on KYV-101’s Clinical Progress and Financial StabilityMay 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kyverna Therapeutics Amidst Positive Clinical Trials and Manufacturing AdvancementsMay 15, 2024 | msn.comKyverna Therapeutics reports Q1 GAAP EPS of -$1.12May 15, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Trading 11.4% Higher Kyverna Therapeutics (NASDAQ:KYTX) Trading Up 11.4%May 15, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Announces Earnings ResultsKyverna Therapeutics (NASDAQ:KYTX - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($1.12) earnings per share for the quarter, missing the consensus estimate of ($0.84) by ($0.28). During the same quarter in the previous year, the company earned ($12.10) EPS.May 15, 2024 | investorplace.comKYTX Stock Earnings: Kyverna Therapeutics Misses EPS for Q1 2024May 14, 2024 | prnewswire.comKyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsMay 13, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Gap Up to $14.00Kyverna Therapeutics (NASDAQ:KYTX) Shares Gap Up to $14.00May 9, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Up 8.7%Kyverna Therapeutics (NASDAQ:KYTX) Shares Up 8.7%May 8, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Stock Price Down 8.9%Kyverna Therapeutics (NASDAQ:KYTX) Trading Down 8.9%May 6, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Reaches New 12-Month Low at $13.89Kyverna Therapeutics (NASDAQ:KYTX) Reaches New 12-Month Low at $13.89May 2, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Down 7.3% Kyverna Therapeutics (NASDAQ:KYTX) Shares Down 7.3%April 30, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Trading 4.5% Higher Kyverna Therapeutics (NASDAQ:KYTX) Shares Up 4.5%April 25, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Trading Down 6.6%Kyverna Therapeutics (NASDAQ:KYTX) Trading Down 6.6%April 24, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Sets New 52-Week Low at $17.70Kyverna Therapeutics (NASDAQ:KYTX) Hits New 52-Week Low at $17.70April 22, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Stock Price Up 6.4%Kyverna Therapeutics (NASDAQ:KYTX) Shares Up 6.4%April 19, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Down 2.8% Kyverna Therapeutics (NASDAQ:KYTX) Trading Down 2.8%April 17, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Hits New 52-Week Low at $21.13Kyverna Therapeutics (NASDAQ:KYTX) Hits New 52-Week Low at $21.13April 17, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kyverna Therapeutics on Promising KYV-101 Drug Efficacy and Safety DataApril 17, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kyverna Therapeutics on Promising KYV-101 Clinical AdvancesApril 11, 2024 | finance.yahoo.comKyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune DiseasesApril 11, 2024 | prnewswire.comKyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune DiseasesApril 8, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Trading Up 5.1%Kyverna Therapeutics (NASDAQ:KYTX) Trading 5.1% HigherApril 3, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Hits New 12-Month Low at $21.71Kyverna Therapeutics (NASDAQ:KYTX) Sets New 52-Week Low at $21.71April 3, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kyverna Therapeutics on Promising Early-Stage KYV-101 Results for MS TreatmentApril 2, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Up 4.6%Kyverna Therapeutics (NASDAQ:KYTX) Trading 4.6% HigherMarch 29, 2024 | finance.yahoo.comFirst-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in MedMarch 29, 2024 | prnewswire.comFirst-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in MedMarch 29, 2024 | markets.businessinsider.comBuy Recommendation: Kyverna Therapeutics’ Innovative Autoimmune Cell Therapy and Robust Pipeline Promise Market LeadershipMarch 29, 2024 | marketbeat.comLeerink Partnrs Comments on Kyverna Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:KYTX)Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Investment analysts at Leerink Partnrs decreased their Q1 2024 earnings per share estimates for shares of Kyverna Therapeutics in a report issued on Wednesday, March 27th. Leerink Partnrs analyst T. Smith now forecasts that the company willMarch 27, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Shares Down 3.5% Kyverna Therapeutics (NASDAQ:KYTX) Stock Price Down 3.5%March 27, 2024 | finance.yahoo.comKyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial ResultsMarch 25, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Reaches New 12-Month Low at $25.09Kyverna Therapeutics (NASDAQ:KYTX) Hits New 1-Year Low at $25.09March 21, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Stock Price Up 6.7%Kyverna Therapeutics (NASDAQ:KYTX) Trading Up 6.7%March 19, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Hits New 1-Year Low at $25.78Kyverna Therapeutics (NASDAQ:KYTX) Reaches New 1-Year Low at $25.78March 18, 2024 | marketbeat.comKyverna Therapeutics (NASDAQ:KYTX) Trading Down 7.7%Kyverna Therapeutics (NASDAQ:KYTX) Stock Price Down 7.7% Get Kyverna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KYTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. KYTX Media Mentions By Week KYTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KYTX News Sentiment▼0.260.76▲Average Medical News Sentiment KYTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KYTX Articles This Week▼54▲KYTX Articles Average Week Get Kyverna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KYTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADMA News CGON News IOVA News VCEL News RXRX News IMCR News KYMR News BEAM News FUSN News SANA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KYTX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored